Ze’ev A. Ronai - Nanotechnology

Author Information

Ze'ev A. Ronai is currently affiliated with the National Cancer Institute (NCI) Cancer Center at the Sanford Burnham Prebys Medical Discovery Institute in La Jolla, California, USA. His extensive contributions to the field of cancer research have established him as a leading figure in understanding the molecular mechanisms driving cancer progression and therapy resistance.

Research Contributions

Ze'ev A. Ronai has made significant strides in cancer research, particularly in understanding tumor biology, immune responses, and the molecular underpinnings of therapy resistance. His recent works include clinically oriented predictions of patient responses to targeted and immunotherapies, the role of ubiquitin ligase RNF5 in acute myeloid leukemia, and the identification of key factors in melanoma progression and therapy resistance. His research is fundamental in developing next-generation cancer therapies and understanding co-vulnerabilities in amino acid-restricted cancers.

Aliases

Ze'ev A. Ronai is also known by various aliases, including Ze′ev Ronai, Z Ronai, Ze'ev A Ronai, Zeev Ronai, and Z A Ronai, among others. These variations appear in different publications and databases, reflecting the diverse ways his name has been recorded over the years.

Publication and Citation Metrics

Total Citations 24,985
H-index 86
Total Papers 410

Publications:

DOI: 10.1016/j.cmet.2020.12.009

Year: 2021

DOI: 10.1016/j.ccell.2021.01.011

Year: 2021

Partnered Content Networks

Relevant Topics